Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors
NCT00195260
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
151
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
bosutinib
DRUG:
bosutinib
DRUG:
bosutinib
DRUG:
bosutinib
Sponsor
Pfizer